Nanospectra Biosciences is a medical device company that is commercializing particle-based therapies for the selective and precise thermal destruction of solid tumors while minimizing damage to healthy adjacent tissue and preserving critical structures. The company was founded on intellectual property from Rice University and collaborative research with scientists at MD Anderson Cancer Center.